Monday, January 17

Failed revolution on the IBEX 35


It seemed like a great opportunity for fresh air to enter the IBEX 35, for the indicator to present a more diversified composition.

In fact, it is one of the few times that the possibility of up to four changes in its components has been discussed.

The meeting held by the IBEX technical advisory committee in December is the one that usually generates the most changes.

Analysts were betting on Acciona Energía, Rovi, Sacyr and Logista to enter the indicator, while Viscofan, Cie Automotive o AlmirallThey were at the exit door.


A single change

Finally there has only been one change, Laboratorios Rovi enters and Viscofan leaves. The revolution has been unsuccessful.

Few could imagine in August, after the crisis suffered in Japan by a series of deaths linked to the Moderna vaccine, that in December Rovi would be part of the select 35 club of the Spanish stock market.

This has been an exceptional year for the pharmaceutical company. Its agreement to produce Moderna vaccines in Spain triggered its shares in the continuous market. Then came the Japan episode and the collapse of their titles.

But the value quickly recovered from that bad moment and is already moving in areas of all-time highs. Although now, as usually happens after its incorporation to the index is announced, it will once again have its ups and downs.

Acciona Energía, Logista and Sacyr will have to wait another moment.

This will be one of the arguments of finance.com today. You will also pay attention to the release of the November CPI for the United States. Investors will be very vigilant because the forecasts are alarming. Inflation is expected to approach 7 percent.



www.finanzas.com